Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-19

Clinical Trial Update: Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease [NA]

View source ↗

Summary

This clinical trial update notes a study evaluating coated or chewable aspirin with a hybrid strategy to mitigate adverse effects of air pollution in stable ath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Rajaie Cardiovascular Medical and Research Center | Conditions: Atherosclerotic Cardiovascular Disease, Coronary Artery Disease | NA | Status: RECRUITING